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Purpose: It is well established that levels of soluble α-crystallin in the lens cytoplasm fall steadily with age, accompanied
by a corresponding increase in the amount of membrane-bound α-crystallin. Less well understood, is the mechanism
driving this age-dependent membrane association. The aim of this study was to investigate the role of the membrane and
its associated proteins and peptides in the binding of α-crystallin.
Methods: Fiber cell membranes from human and bovine lenses were separated from soluble proteins by centrifugation.
Membranes were stripped of associated proteins with successive aqueous, urea, and alkaline solutions. Protein constituents
of the respective membrane isolates were examined by SDS–PAGE and western immunoblotting. Recombinant αA- and
αB-crystallins were fluorescently-labeled with Alexa350® dye and incubated with the membrane isolates and the binding
capacity of membrane for α-crystallin was determined.
Results: The binding capacity of human membranes was consistently higher than that of bovine membranes. Urea- and
alkali-treated membranes from the nucleus had similar binding capacities for αA-crystallin, which were significantly
higher than both cortical membrane extracts. αB-Crystallin also had a higher affinity for nuclear membrane. However,
urea-treated nuclear membrane had three times the binding capacity for αB-crystallin as compared to the alkali-treated
nuclear membrane. Modulation of the membrane-crystallin interaction was achieved by the inclusion of an NH2-terminal
peptide of αB-crystallin in the assays, which significantly increased the binding. Remarkably, following extraction with
alkali, full length αA- and αB-crystallins were found to remain associated with both bovine and human lens membranes.
Conclusions: Fiber cell membrane isolated from the lens has an inherent capacity to bind α-crystallin. For αB-crystallin,
this binding was found to be proportional to the level of extrinsic membrane proteins in cells isolated from the lens nucleus,
indicating these proteins may play a role in the recruitment of αB-crystallin. No such relationship was evident for αA-
crystallin in the nucleus, or for cortical membrane binding. Intrinsic lens peptides, which increase in abundance with age,
may also function to modulate the interaction between soluble α-crystallin and the membrane. In addition, the tight
association between α-crystallin and the lens membrane suggests that the protein may be an intrinsic component of the
membrane structure.
The human lens grows continuously throughout life via
the addition of new fiber cells on top of preexisting ones. This
process leads to the formation of two lens regions referred to
as the nucleus, consisting of fiber cells formed in utero, and
an ever-expanding cortex which consists of fiber cells formed
post-natally  [1,2].  Lens  fiber  cells  contain  a  high
concentration of the structural proteins α-, β- and γ-crystallins,
which contribute significantly to the transparent and refractive
properties of the lens. α-Crystallin, which is composed of
subunits αA and αB, functions additionally as a molecular
chaperone [3,4]. As there is little to no protein turnover in
mature lens fiber cells [5], the long-term transparency of the
lens is dependent on the ability of α-crystallin to sequester
unfolded proteins and maintain them in soluble chaperone-
client complexes.
Lens proteins undergo a multitude of posttranslational
modifications during aging, which over time contribute to the
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unfolding and denaturation of crystallins [6-12]. With age, the
level of unfolded proteins eventually exceeds the chaperone
capacity of α-crystallin in the lens, such that by 40 years, all
free  α-crystallin  in  the  lens  has  been  used  [13-15].
Subsequently, the level of water-insoluble and high molecular
weight crystallin aggregates in the lens increases significantly
[16-19].  Large-scale  binding  of  α-crystallin  to  lens
membranes has also been documented in the lens with age
[20-22], and this has been hypothesized to contribute to the
development  of  nuclear  cataract  by  occluding  membrane
pores, thus leading to the formation of a barrier to diffusion
[22-24].
The association between crystallins and lens fiber cell
membranes is believed to be an important process by which
crystallin insolubilization occurs in the aging lens [22,25,26].
Chandrasekher and Cenedella [25] showed that essentially all
water-insoluble  crystallins  in  old  human  lenses  are
membrane-bound.  α-Crystallin,  in  particular,  has  a  strong
affinity toward lens membrane [20,21,27-30], leading to the
suggestion that the overall increase in the membrane binding
of crystallins in the lens is due to other crystallins associating
with membrane-bound α-crystallin [27]. However, little is
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2798currently  known  about  the  mechanism(s)  by  which  α-
crystallin associates with the cellular membrane, and how age-
related changes to the membrane compositions may affect
crystallin-binding.
In this study, we examined the protein constituents of
bovine and human lens membranes after successive removal
of  extrinsic  protein.  We  report  the  effects  of  residual
membrane-associated  proteins  on  the  binding  behavior  of
recombinant α-crystallin and the effect upon this binding of a
known intrinsic lens peptide.
METHODS
Isolation of bovine and human lens fiber cell membranes: A
total of 142 human lenses, aged between 54 and 84 years, were
obtained from donors at the Lions New South Wales Eye Bank
(Sydney, Australia). Tissue was handled in accordance with
the tenets of the Declaration of Helsinki. Fresh bovine lenses
were obtained from a local abattoir. All lenses were stored at
−80 °C before dissection.
Lenses were separated into cortical and nuclear regions
using a 4.5 mm diameter trephine. A cold scalpel was used to
remove  1  mm  of  tissue  from  each  end  of  the  resulting
cylindrical center (nucleus). The cortical and nuclear tissues
from human lenses and the cortical tissues from the bovine
lenses were used in this study. Lens membranes were obtained
using methods published by Russell et al. [31] with minor
modifications. Briefly, lens tissues were homogenized in 7
times (w/w) of buffer A (50 mM Tris-HCl, 5 mM EDTA,
10 mM β-mercaptoethanol, 0.2% sodium azide, pH 7.4) and
incubated at room temperature for 10 min. The homogenate
was centrifuged at 15,000× g for 20 min at 4 °C, and the
supernatant was discarded. The pellet was re-homogenized in
buffer A and centrifuged at 15,000× g for another 20 min. The
resulting pellet was washed with MilliQ™ water (Kilsyth, Vic
Australia),  centrifuged  and  re-homogenized  in  buffer  B
(50 mM Tris-HCl, 7 M urea, pH 7.4). The urea concentration
in the homogenate was diluted to 3.5 M with water and the
homogenate was centrifuged at 15,000× g for 20 min. This
extraction procedure using buffer B was repeated and the
resulting pellet was washed three times with water to give the
urea-treated  membrane.  To  obtain  the  alkali-treated
membrane, a portion of the urea-treated membrane pellet was
re-homogenized in solution containing 0.1 M NaOH, 1 mM
β-mercaptoethanol. The homogenate was incubated on ice for
15 min and then centrifuged at 15,000× g for 20 min at 4 °C.
The pellet was further washed with 5 mM phosphate (pH 8.0),
followed by two washes with water.
Isolated membranes were re-suspended in binding buffer
(137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM
K2HPO4, 5 mM MgCl2, pH 7.3). Quantification of membrane
samples was achieved by weighing freeze-dried aliquots of
the membrane suspension using an Excellence XS105 dual-
range  analytical  balance  (Mettler  Toledo,  Greifensee,
Switzerland). The concentration of membrane tissue (mg/ml)
in the suspension was calculated by averaging at least four
separate aliquots. Light absorbance of membrane samples at
different wavelengths (220–850 nm) was measured using a
POLARstar Omega multifunction microplate reader (BMG
Labtech, Offenburg, Germany).
SDS–PAGE and western immunoblot analysis of bovine and
human lens membranes: Proteins in the bovine and human
lens  membrane  preparations  were  examined  using  SDS–
PAGE  and  western  immunoblots.  Samples  were
homogenized in SDS–PAGE loading buffer (60 mM Tris-
HCl, 1% SDS, 1% β-mercaptoethanol, 10% glycerol, 0.01%
bromophenol blue, pH 6.8) and incubated at room temperature
for 2 h before loading onto 12% SDS–PAGE gels. Heating of
the sample was avoided as elevated temperatures can damage
the structure of intrinsic membrane proteins [31]. All SDS–
PAGE gels were stained with Coomassie Blue R (Sigma-
Aldrich, St. Louis, MO). For western immunoblot analysis,
antibodies which specifically recognize human and bovine
filensin, phakinin, αA- and αB-crystallins were used and were
diluted to their working concentrations using PBS/T (137 mM
NaCl, 2.7 mM KCl, 12.5 mM Na2HPO4, 1.8 mM KH2PO4,
0.05% (v/v) Tween-20, pH 7.4) containing 0.5% (w/v) skim
milk  powder.  Proteins  separated  by  SDS–PAGE  were
transferred onto polyvinylidene fluoride membranes at 30 V
overnight at 4 °C using the Mini Trans-Blot system (Bio-Rad,
Hercules, CA). Membranes were blocked for 1 h at room
temperature in PBS/T containing 5% (w/v) skim milk powder.
After three 10 min washes with PBS/T, the membranes were
incubated with either a 1:1,000 dilution of polyclonal anti-
αA-crystallin antibody (ab69552; Abcam, Cambridge, MA),
a 1:1,000 dilution of polyclonal anti-αB-crystallin antibody
(ab13497; Abcam), a 1:1,500 dilution of monoclonal anti-
filensin  antibody  (F1043;  Sigma-Aldrich),  or  a  1:5,000
dilution  of  monoclonal  anti-vimentin  antibody  (V6389;
Sigma-Aldrich) for 90 min at room temperature. Following
another three 10 min washes with PBS/T, the membranes were
incubated  for  1  h  with  a  1:1,500  dilution  of  anti-rabbit
immunoglobulin  G  (IgG)  horseradish  peroxidase  (HRP)
conjugate (65–6120; Invitrogen, Carlsbad, CA) for anti-αA-
crystallin and anti-αB-crystallin blots, or a 1:2,500 dilution of
goat anti-mouse IgG HRP conjugate (SAB-100J; Stressgen,
Ann  Arbor,  MI)  for  anti-filensin  and  anti-vimentin  blots.
Excess secondary antibodies were removed by three 10 min
washes with PBS/T, and the blots were developed in 100 mM
Tris-HCl (pH 7.6) containing 1.4 mM diaminobenzidine and
0.015% (v/v) hydrogen peroxide.
Quantification  of  phospholipids:  Phospholipids  were
quantified  by  mass  spectrometry  as  described  previously
[32]. Briefly, lenses were frozen under liquid nitrogen and
ground using a mortar and pestle. Chloroform:methanol (2:1
v/v) containing 0.01% butylated hydroxytoluene was added
to the lens material at a ratio of 20:1 solvent to tissue (v/w).
After  rotating  overnight,  total  lipids  were  extracted,  and
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Manchester, U.K.) equipped with a z-spray electrospray ion
source and controlled by Micromass Masslynx version 4.0
software. To identify each phospholipid, a combination of
precursor and neutral loss scans were used to detect the head-
group of each phospholipid class [33]. Each phospholipid
class was quantified by comparing their peak areas with the
appropriate  internal  standard  after  correction  for  isotope
contributions [32]. The percentage of each phospholipid was
than determined by its contribution to the total phospholipid.
Overexpression and purification of recombinant human αA-
and  αB-crystallins:  The  pET23d(+)  plasmid,  containing
human wild-type αA-crystallin gene, was a gift from Prof. J.
M.  Petrash  (Washington  University,  St.  Louis,  MO).  The
pET24d(+)  plasmid  (Novagen,  Madison,  WI),  containing
human wild-type αB-crystallin gene, was a gift from Prof. W.
de  Jong  (University  of  Nijmegen,  Nijmegen,  The
Netherlands).  Plasmids  were  transformed  into  electro-
competent Escherichia coli BL21 cells by electroporation
using a GenePulser II system (Bio-Rad). LB stocks (900 ml;
1% tryptone, 0.5% yeast extract, 1% NaCl) that contained
ampicillin  (100  µg/ml)  or  kanamycin  (50  µg/ml)  were
inoculated with 100 ml of overnight liquid cultures of BL21/
pET23d-αA  or  BL21/pET24d-αB  cells,  respectively,  and
grown at 37 °C under vigorous shaking. The culture was
induced  with  10  ml  of  50  mM  isopropyl  β-D-1-
thiogalactopyranoside  after  reaching  an  optical  density  of
~0.5 at 600 nm, and further incubated for 3 h at 37 °C. Cells
were harvested by centrifugation, and the expressed proteins
were isolated using methods by Horwitz et al. [34]. Briefly,
frozen cell pellets were resuspended in ice-cold lysis buffer
(50  mM  Tris-HCl,  100  mM  NaCl  pH  8.0)  containing
phenylmethanesulfonylfluoride  (130  µM)  and  800  µg/ml
lysozyme.  After incubation on ice for 20 min, deoxycholic
acid (4 mg per g of starting pellet) was added followed by
vigorous shaking at 37 °C.  Cell disruption was completed
using a French Press Cell Disruptor as per manufacturer’s
instructions  (ThermoFisher  Scientific,  Scoresby  Vic
Australia).  Cell  debris  was  removed  from  lysates  by
centrifugation at 17,000× g for 15 min at 4 °C. Recombinant
human  αA  and  αB-crystallin  were  purified  from  the  cell
lysates using anion-exchange chromatography (HiPrep 16/10
DEAE  FF  column;  GE  Healthcare,  Little  Chalfont,  UK),
followed by size-exclusion chromatography (HiPrep 26/60
Sephacryl S-300 column; Amersham Biosciences, Uppsala,
Sweden).
Conjugation  of  Alexa350®  to  α-crystallin  subunits:
Alexa350®  fluorescent  tag  (410  Da)  was  conjugated  to
recombinant αA- and αB-crystallins using an Alexa Fluor®
350  Protein  Labeling  Kit  (A10170,  Molecular  Probes,
Carlsbad,  CA),  in  accordance  with  the  manufacturer’s
instructions. Briefly, recombinant proteins in PBS (2 mg/ml)
were mixed with 1 M sodium bicarbonate (10:1 v/v). The
reactive dye was added to the protein solution and left for 1 h
at room temperature.  Unincorporated dye was removed by
size exclusion chromatography using BioGel P-30 Fine resin
supplied with the kit. Purified Alexa350®-conjugated αA- and
αB-crystallins were measured using absorbance readings at
280 nm and 346 nm (A280 and A346) on a UVmini-1240 UV-
VIS  spectrophotometer  (Shimadzu,  Kyoto,  Japan).  The
protein  concentration  and  the  degree  of  binding  were
determined using the following equations:
Where 0.19 is a correction factor to account for absorption of
Alexa350®  at  280  nm,  19000  is  the  molar  extinction
coefficient for Alexa350® and εprotein is the molar extinction
coefficient for α-crystallin.
Membrane  binding  measurements:  Alexa350®-conjugated
αA-  and  αB-crystallins  were  incubated  with  bovine  and
human lens membranes in binding buffer at 37 °C for 6 h,
based on protocols established previously [30]. Control assays
were set up by replacing Alexa350®-α-crystallin subunits with
unlabeled α-crystallin subunits. All assays were performed in
triplicate.  After  incubation,  samples  were  centrifuged  at
14,000× g for 30 min at 4 °C. The pellets were re-suspended
in 30 μl of binding buffer and centrifuged again at 14,000× g
for 30 min at 4 °C. The supernatants from both centrifugations
were pooled together. The resulting pellets, which contained
the membrane, and bound Alexa350®-α-crystallin subunits,
were re-suspended in a volume of binding buffer equivalent
to that of the combined supernatants. Both the supernatants
and  the  re-suspended  pellets  were  transferred  to  96-well
polypropylene  black  microplates  (Greiner  Bio-One,
Frickenhausen, Germany), and the fluorescence reading (F)
of  the  samples  was  measured  using  a  FLUOstar  Optima
multifunction  microplate  reader  (BMG  Labtech).  The
excitation and emission filters were set at 320–340 and 430–
450  nm  respectively.  The  degree  of  binding  (X ¯)  was
determined  by  the  following  formula,  where  background
fluorescence  readings  were  obtained  from  control  assays
(using unlabeled α-crystallin):
The amount of α-crystallin subunits bound to the membranes
was calculated by multiplying the total mass of Alexa350®-
α-crystallin subunits used in the assay by the degree of binding
(X ¯).
Effect of endogenous crystallin peptides on the membrane
binding  of  α-crystallin:  Peptide  αB1–18  (Ac-
MDIAIHHPWIRRPFFPFH) was purchased from Biomatik
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2800(Cambridge,  Ontario,  Canada)  with  sample  purity  ≥95%.
Peptide  γS167–178  (SPAVQSFRRIVE)  was  purchased  from
Peptide 2.0 (Chantilly, VA) with sample purity of ≥91%.
Peptides were solubilized in binding buffer to give a 4 g/l stock
solution. Peptides were drawn from the stock solution and
incubated with human lens membranes (80 μg) for 30 min at
37 °C. These were then incubated for 6 h at 37 °C in the
presence  of  24  μg  of  Alexa350®-conjugated  αA-  or  αB-
crystallin,  or  24  μg  of  unlabeled  αA-  or  αB-crystallin  as
negative  controls.  Binding  assays  were  performed  as
described previously. Peptide interaction data were analyzed
using unpaired two-sample t-test.
RESULTS
Analysis  of  proteins  associated  with  lens  fiber  cell
membranes:
Bovine lens membranes—SDS–PAGE analysis of the
urea-treated bovine (BU) membrane (Figure 1) showed that
multiple proteins, ranging from 10 kDa to above 200 kDa,
remain bound to the bovine lens membrane after the combined
extractions of Tris- and urea-containing buffers. α-Crystallin
subunits A and B (~20 kDa) were the predominant species
detected, as shown by western immunoblots (Figure 1). In
contrast, the alkali-treated bovine (BA) lens membrane extract
contained no protein that could be detected by Coomassie
staining.
Western immunoblots (Figure 1) revealed that both αA-
and αB-crystallins (both ~20 kDa) were present in the BU and
BA  lens  membranes,  with  a  significant  amount  of  higher
molecular weight immuno-reactive protein also detected in
the BU. Following further treatment of the membranes with
alkali, α-crystallin subunits and a ~50 kDa αA species of
protein remained (Figure 1). Of the two major intermediate
filament proteins of the lens fiber cell cytoskeleton, intact
filensin (115 kDa) and multiple cleavage products of filensin
were  detected  only  in  the  BU  membrane,  while  vimentin
(54  kDa)  was  present  in  both  bovine  lens  membrane
preparations (Figure 1).
Human  lens  membranes—SDS–PAGE  analysis
(Figure 2) revealed human lens membrane to be very different
from  bovine  lens  membrane.  Three  proteins  of  ~20  kDa,
22 kDa and 26 kDa, which correspond to αA/αB-crystallin,
major intrinsic protein (MIP) 22 and MIP26 respectively,
were present in all human lens membrane preparations (Figure
2).  The  urea-treated  membrane  preparations,  particularly
urea-treated  nucleus  (NU)  membrane,  showed  noticeable
smearing  down  the  length  of  the  gel.  In  addition,  a  low
molecular weight (LMW) band which migrated with the dye-
front was observed, which was particularly intense in the urea
extracts. The presence of this band indicates that significant
amounts of LMW peptides, likely derived from crystallins
[35-37], remain tightly associated with the lens membranes
after extraction with urea.
Western  immunoblots  detected  intact  αA-  and  αB-
crystallins  (~20  kDa)  in  all  human  lens  membrane
preparations, even after the membranes had been stripped of
the majority of extrinsic proteins with strong alkali solution
(Figure 2). A diffuse band at ~43 kDa was also present in each
of the αA-crystallin blots, with additional smearing between
70 kDa and 130 kDa, being particularly noticeable in the
alkali-treated  nuclear  (NA)  preparation.  On  the  anti-αB-
crystallin blots, extensive smearing was observed in the lanes
of  the  urea-treated  membranes,  some  of  which  may  be
attributed  to  non-specific  immunoreactivity  as  described
above.  Interestingly,  a  variety  of  smaller  αB-crystallin
products  less  than  20  kDa  remained  bound  to  the  lens
membrane after urea-treatment (Figure 2). Most of the anti-
αB reactive proteins were removed upon treatment with 0.1
M  NaOH,  except  for  some  intense  smearing  from  90  to
150 kDa. Smearing was also observed on the anti-filensin
Figure  1.  SDS–PAGE  and  western
immunoblot  analysis  of  bovine  lens
membranes.  The  water-insoluble  cell
membrane  pellets  from  bovine  lens
homogenates  washed  with  7  M  urea
(BU)  and  with  0.1  M  NaOH  (BA).
Samples were analyzed by SDS–PAGE
(100  μg  of  membrane  per  lane)  and
western  immunoblotting  (20  μg  of
membrane per lane). Blots were probed
using  anti-αA-crystallin,  anti-αB-
crystallin,  anti-filensin  and  anti-
vimentin  antibodies,  as  indicated.
Molecular weight markers are on the left
of the figure.
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2801blots of the urea-treated human lens membrane, while no
filensin was detected in the alkali-treated membranes (Figure
2). Vimentin was only detected in the cortical human lens
membrane preparations (Figure 2).
Binding of α-crystallin subunits to lens membranes:
Purification  of  Alexa350®-α-crystallin  subunits—
Recombinant  human  αA-  and  αB-crystallins  were
overexpressed in E. coli and conjugated to Alexa350®. On
average, 0.56±0.07 mol of Alexa350® was attached per mol
of αA-crystallin, and 0.44±0.36 mol of Alexa350® per mol of
αB-crystallin.
Bovine  lens  membrane  binding—To  compare  the
binding of α-crystallins to bovine and human lens membranes,
we  pre-labeled  recombinant  αA-  and  αB-crystallins  with
Alexa350®, whose excitation and emission characteristics are
spectrally distinct from aromatic amino acids. Binding assays
using BU and BA membranes displayed saturable binding
behavior  (Figure  3),  which  allowed  us  to  calculate  the
membrane binding capacity from the asymptote of each curve
(Table  1).  The  binding  capacities  for  αA-crystallin  were
28.1±2.4 ng αA/μg BU membrane, and 19.5±0.8 ng αA/μg
BA membrane. The binding capacities for αB-crystallin were
lower, being 19.1±1.1 ng αB/μg BU membrane and 6.0±0.6
ng αB/μg BA membrane.
Human  lens  membrane  binding—All  of  the  assays
using human lens membranes displayed saturable binding of
the  Alexa350-α-crystallins  (Figure  4),  and  the  binding
capacity  was  greater,  on  the  whole,  than  bovine  lens
membranes  (Table  1).  Comparing  regions,  a  matched
treatment  analysis  revealed  that  nuclear  membrane  had
significantly greater binding capacity for the α-crystallins than
cortical  membrane  (p<0.05).  Matched  region  analysis
indicated the difference in binding due to solvent treatment is
less  significant  (p>0.1).  For  example,  αA-crystallin  was
observed to bind NU and NA membrane with less than 20%
difference in capacity, while CU and CA displayed almost
identical  αA-crystallin  binding  capacity.  αB-Crystallin,
however, exhibited significantly greater binding to the NU
membrane  than  the  NA  membrane  (208.0±13.1  ng/μg
compared with 67.0±2.4 ng/μg). This result strongly suggests
that proteins removed from the nuclear membrane by the
alkali treatment have a much higher affinity for αB-crystallin
than the extrinsic proteins of the cortex membrane.
Membrane  lipid  analysis  revealed  no  significant
alteration  in  the  ratios  of  the  eight  major  classes
(dihydrosphingomyelin,  sphingomyelin,
phosphatidylcholine,  phosphatidylserine,  ceramide,
dihydroceramide,  phosphatidylethanolamine,  and
lysophosphatidylethanolamine)  between  the  human
Figure  2.  SDS–PAGE  and  western
immunoblot  analysis  of  human  lens
membranes.  Isolated  cortical  and
nuclear lens membranes were extracted
with 7 M urea in Tris buffer (CU – cortex
urea; NU – nucleus urea) and with 0.1
M NaOH (CA – cortex alkali; NA –
nucleus alkali). Samples were analyzed
by SDS–PAGE (100 μg of membrane
per  lane)  and  with  western
immunoblotting  (20  μg  of  membrane
per lane). Blots were probed using anti-
αA-crystallin,  anti-αB-crystallin,  anti-
filensin and anti-vimentin antibodies, as
indicated. Molecular weight markers are
on the left of the figure.
Figure  3.  Binding  of  α-crystallin  to
bovine  lens  membrane  preparations.
Binding curves depicting the amount of
bound Alexa350®-conjugated αA- (A)
and αB-crystallin (B) per μg of urea-
treated (●) or alkali-treated (▲) bovine
lens membrane as a function of the free
α-crystallin concentration. Bovine lens
membranes  (200  μg)  were  incubated
with  a  mass  range  of  Alexa350®-
conjugated αA- and αB-crystallins, for
6 h at 37 °C. Results are the mean±SEM
(n=3).
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2802membrane preparations used in these binding assays (Figure
1A, Appendix 1), demonstrating that membrane binding of
α-crystallin was not influenced by changes to the proportion
of  individual  membrane  lipids.  Human  membrane
preparations displayed no significant absorbance between 380
and 500 nm (Figure 2A, Appendix 2), indicating there would
be minimal interference with the fluorescent signal emitted by
the Alexa350® dye.
Effect of crystallin peptides on the membrane binding of α-
crystallin  subunits:  In  a  recent  study,  we  reported  that
crystallin peptides αB1–18 and γS167–178 were present in human
lenses across a broad age-range [36]. Santhoshkumar et al.
[35] reported that peptide αB1–18 possessed anti-chaperone
activity against α-crystallin, while peptide γS167–178 had little
effect. Peptide αB1–18 was found to significantly increase the
amount of membrane-bound α-crystallin subunits in all but
the CU membranes (Figure 5). In the case of αA-crystallin,
the addition of peptide αB1–18 increased the binding by 59%
(NU  membrane),  72%  (CA  membrane)  and  72%  (NA
membrane). Similar results were observed in binding assays
using  αB-crystallin,  with  the  amount  of  membrane-bound
αB-crystallin increasing by 61% (CA membrane) and 69%
(NA membrane). However, peptide αB1–18 did not give rise to
a significant increase in binding of αB-crystallin to the urea-
treated membranes (Figure 5B), possibly due to the amount
of endogenous αB-crystallin that is present on this membrane
preparation (Figure 2). The addition of peptide γS167–178 had a
negligible effect on the binding of both αA- and αB-crystallins
to all human lens membrane preparations (Figure 5).
DISCUSSION
There is growing evidence that association with fiber cell
membranes  is  an  important  process  by  which  crystallins
become  water-insoluble  in  the  lens  [22,25,30].  This
association may also contribute to the age-dependent loss of
free α-crystallin [13-15]. In addition, large-scale binding of
crystallin aggregates after middle age [22,23] is implicated in
the development of the lens barrier – a significant event in the
human  lens  that  is  associated  with  subsequent
cataractogenesis [24,38,39]. Building upon previous studies,
where the membrane binding of α-crystallin was characterized
using  non-human  lens  tissues  [26,30,40-44],  here  we
determined  the  binding  properties  of  α-crystallin  to
membranes isolated from both bovine and human lens tissues.
αA- and αB-crystallins were the dominant membrane-
bound proteins in the bovine lens after extraction with urea,
whereas  the  human  membrane  also  contained  significant
amounts  of  aquaporin  0  (AQP0,  [MIP26,  MIP22]),  small
peptides and, particularly in the nucleus, a complex mixture
of cytoskeletal and crystallin proteins. Full-length αA- and
αB-crystallins  remained  tightly  associated  with  both  the
TABLE 1. BINDING CAPACITY OF BOVINE AND HUMAN LENS MEMBRANES FOR ALEXA350®-Α-CRYSTALLIN SUBUNITS.
Membrane samples αA binding capacity (ng/μg membrane) αB binding capacity (ng/μg membrane)
BU 28.1±2.4 19.1±1.1
BA 19.5±0.8 6.0±0.6
CU 31.5±2.0 54.3±4.2
CA 33.4±2.8 31.6±1.8
NU 95.4±4.2 208.0±13.1
NA 78.5±2.0 67.0±2.4
        Abbreviations used: BU – urea-treated bovine membrane; BA – alkali-treated bovine membrane; CU – urea-treated human
        cortical membrane; CA – alkali-treated human cortical membrane; NU – urea-treated human nuclear membrane; NA – alkali-
        treated human nuclear membrane.
Figure  4.  Binding  of  α-crystallin  to
human  lens  membrane  preparations.
Binding curves depicting the amount of
bound Alexa350®-conjugated αA- (A)
and αB-crystallin (B) per μg of urea-
treated  cortical  (●)  and  nuclear  (▲)
human lens membrane, or alkali-treated
cortical (○) and nuclear (△) human lens
membrane as a function of the free α-
crystallin  concentration.  Human  lens
membranes (80 μg) were incubated with
a mass range of Alexa350®-conjugated
αA- and αB-crystallins, for 6 h at 37 °C.
Results are the mean±SEM (n=3).
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2803bovine and human lens membranes after extraction with 7 M
urea, and remarkably, even after the alkali-treatment. The
presence  of  α-crystallin  after  such  vigorous  treatment
indicates  that  it  is  very  tightly  associated  with,  or  even
partially  embedded  in  the  fiber  cell  membrane.  To  our
knowledge, this is the first evidence which suggests that α-
crystallins may be an intrinsic component of the lens fiber cell
membrane. Given the important role that α-crystallin has on
the structural assembly of the beaded filaments [45,46], the
incorporation  of  α-crystallin  into  the  fiber  cell  membrane
structure  may  have  functional  significance  regarding  the
stability and order of the lipid bilayer. Furthermore, fatty acid
acylation, which confers membrane anchoring properties to
proteins, and has been reported for lens AQP0 [47], may also
contribute to the tight association between α-crystallin and the
lens  membrane,  if  α-crystallin  subunits  are  acylated  in  a
similar manner.
We observed that the level of αB-, but not αA-crystallin,
binding to the bovine and human membranes was influenced
by the extent to which the membrane had been stripped of
extrinsic  proteins.  This  may  be  due  to  the  fact  that  αB-
crystallin  is  a  more  potent  chaperone  at  physiologic
temperatures (37–40 °C) compared to αA-crystallin [48], and
that membrane-bound proteins represent potential chaperone
targets. As the alkali-treated membranes were largely stripped
of this membrane-bound protein, the interacting targets for
αB-crystallin  decreased  significantly,  thus  lower  binding
capacity  was  observed.  These  results  suggest  that  the
mechanisms by which αA- and αB-crystallins associate with
the  cellular  membrane  are  different;  αA-crystallin  may
interact exclusively with membrane phospholipids, thereby
being unaffected by the presence of extrinsic proteins on the
membrane, whereas these proteins may act as conduits for
αB-crystallin to bind to the membrane.
Membrane binding of both αA- and αB-crystallins was
significantly increased in the presence of peptide αB1–18. It has
previously been reported that when mixed with wild-type αB-
crystallin, peptide αB1–18 increased the oligomeric size of the
protein [49]. Thus, our results may reflect the fact that larger
α-crystallin  oligomers  containing  greater  numbers  of  α-
crystallin subunits are binding to the membrane. Considering
that the emergence of this peptide in the lens nucleus [36]
corresponds  to  the  time  when  large-scale  binding  of  α-
crystallin to lens membrane is observed [22], this and other
endogenous peptides [35,36] may play a role in this process.
Previous studies into membrane binding of α-crystallin
have produced conflicting outcomes. For example, Ifeanyi et
al. [42] found that the association of α-crystallin to membranes
was mainly due to the αA subunit. In contrast, Cobb and
Petrash [30] suggested that αA and αB subunits have similar
binding capacities to lens membranes. Typically, membrane
binding  studies  were  performed  using  non-human  lens
membranes.  As  the  membrane  binding  of  α-crystallin  is
affected by the presence of membrane-bound proteins, and
endogenous peptides, the use of non-human tissue does not
appear to represent a useful model for the aging human lens.
Recent studies have also shown that the lipid composition
of human lens membrane differs considerably from that of
other  mammalian  animals  [32].  The  levels  of
dihydrosphingomyelin and cholesterol are much higher in
human lenses [32], and these hydrophobic components [50]
could mimic the exposed hydrophobic residues on substrate
proteins, with which α-crystallin is known to interact [51,
52].  Another  characteristic  of  the  human  lens  is  that  its
phospholipids undergo major changes with age. The levels of
glycerophospholipids  in  the  nucleus  of  the  lens  decline
steadily, such that by age 40, their content is negligible [53].
In contrast, the levels of ceramides and dihydroceramides in
Figure 5. Effect of crystallin peptides on
the binding of α-crystallin to human lens
membranes.  Graphs  showing  the
amount (ng) of Alexa350®-conjugated
αA- (A) or αB-crystallin (B) bound per
μg  of  human  lens  membrane  in  the
presence of crystallin peptides. Human
lens  membranes  (80  μg)  were  mixed
with either 48 μg of peptide αB1–18 (solid
bars), 48 μg of peptide γS167–178 (dotted
bars),  or  with  binding  buffer  only
(horizontal  line  bars),  for  30  min  at
37  °C.  Alexa350®-conjugated  αA-  or
αB-crystallin (24 μg) was then added
and the mixtures were incubated for 6 h
at 37 °C. Results are the mean±SEM
(n=3). *p<0.05, **p<0.01, ***p<0.001
compared with assays performed with
binding  buffer  only  (horizontal  line
bars).
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2804the  lens  nucleus  increase  approximately  100  fold  during
middle-age  [53].  It  is  therefore  possible  that  age-related
changes to membrane phospholipids are influential in the
binding of α-crystallin and the persistence of this versatile
small heat-shock protein may also be an important component
of the fiber cell membrane itself.
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2806Appendix  1.  Relative  ratio  of  phospholipids  in  human  lens  membrane
preparations.
Shown  are  the  relative  quantities  of  phospholipids
(DHSM:  dihydrosphingomyelin,  SM:  sphingomyelin,  PC:
phosphatidylcholine,  PS:  phosphatidylserine,  PE:
phosphatidylethanolamine,  Cer:  ceramide,  DHC:
dihydroceramide  and  PE  lyso:
lysophosphatidylethanolamine) present in the cortical urea
(CU, red bars), cortical alkali (CA, green bars), nuclear urea
(NU, yellow bars) and nuclear alkali (NA, blue bars) human
lens membranes. To access the data, click or select the words
“Appendix 1.” This will initiate the download of a compressed
(pdf) archive that contains the file.
Appendix 2. Relative absorbance of the human lens membrane.
Graph showing the relative absorbance of the urea-treated
cortical (dark blue line) and nuclear (red line) membranes, and
the alkali-treated cortical (green line) and nuclear (violet line)
membranes between 380-500 nm. Binding buffer (light blue
line) was used as negative control. To access the data, click
or  select  the  words  “Appendix  2.”  This  will  initiate  the
download of a compressed (pdf) archive that contains the file.
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